Literature DB >> 3278950

Vascular effects of oxygen-derived free radicals.

G M Rubanyi1.   

Abstract

This review attempts to summarize the available data regarding the vascular actions of free oxygen radicals. Studies on blood vessels in situ and in vitro demonstrate that free oxygen radicals can evoke both vasodilation and vasoconstriction. Free oxygen radicals can modulate the tone of vascular smooth muscle by acting directly on the smooth muscle cells, and also via indirect mechanisms by changes in the production or biological activity of vasoactive mediators. The individual oxygen radicals may have different (sometimes opposite) vascular effects. Superoxide anion inactivates endothelium-derived relaxing factor and the adrenergic neurotransmitter norepinephrine. Hydrogen peroxide and the hydroxyl radical evoke vasodilation by acting directly on vascular smooth muscle and also by stimulating the synthesis/release of endothelium-derived relaxing factor. In acute arterial hypertension or experimental brain injury oxygen radicals are important mediators of vascular damage. Production of oxygen-derived free radicals by activated neutrophils may be responsible for vasodilation and increased permeability of capillary membrane during the acute inflammatory process. Free oxygen radicals also play an important role in reperfusion injury of various organs, and vascular actions of the free radicals may contribute to the damage of parenchymal tissues.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3278950     DOI: 10.1016/0891-5849(88)90071-8

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  22 in total

1.  Oxidative inhibition of the vascular Na+-K+ pump via NADPH oxidase-dependent β1-subunit glutathionylation: implications for angiotensin II-induced vascular dysfunction.

Authors:  Chia-Chi Liu; Keyvan Karimi Galougahi; Robert M Weisbrod; Thomas Hansen; Ramtin Ravaie; Andrea Nunez; Yi B Liu; Natasha Fry; Alvaro Garcia; Elisha J Hamilton; Kathleen J Sweadner; Richard A Cohen; Gemma A Figtree
Journal:  Free Radic Biol Med       Date:  2013-06-28       Impact factor: 7.376

Review 2.  Reactive oxygen molecules, oxidant injury and renal disease.

Authors:  S P Andreoli
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

3.  Are worry-free transfusions just a whiff of ozone away?

Authors:  A C Baggs
Journal:  CMAJ       Date:  1993-04-01       Impact factor: 8.262

Review 4.  The vascular endothelium. A new horizon.

Authors:  M G Davies; P O Hagen
Journal:  Ann Surg       Date:  1993-11       Impact factor: 12.969

5.  Induction of renal growth and injury in the intact rat kidney by dietary deficiency of antioxidants.

Authors:  K A Nath; A K Salahudeen
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

6.  A New Hypothesis for Insulin Resistance in Hypertension Due to Receptor Cleavage.

Authors:  Frank A Delano; Hanrui Zhang; Edward E Tran; Cuihua Zhang; Geert W Schmid-Schönbein
Journal:  Expert Rev Endocrinol Metab       Date:  2010-01-01

7.  Reappraisal of the e.p.r. signals in (post)-ischaemic cardiac tissue.

Authors:  A M van der Kraaij; J F Koster; W R Hagen
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

8.  Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbits.

Authors:  George S G Shehatou; Ghada M Suddek
Journal:  Exp Biol Med (Maywood)       Date:  2015-10-20

9.  Superoxide and peroxynitrite in atherosclerosis.

Authors:  C R White; T A Brock; L Y Chang; J Crapo; P Briscoe; D Ku; W A Bradley; S H Gianturco; J Gore; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

10.  Leptin's activity on the hydroxyl radical: a possible link to the oxidative stress-related endothelial vasodilation in patients with obstructive sleep apnea.

Authors:  Madalina Macrea; Thomas Martin; Zhenquan Jia; Hara Misra
Journal:  Lung       Date:  2013-05-21       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.